Pfizer’s COVID-19 vaccine faced EMA manufacturing concerns before the emergency wave: report
About a month before Pfizer and BioNTech won an emergency approval for their COVID-19 vaccine in Europe, regulators raised flags about lower than expected levels of intact mRNA in commercial batche…
